Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Bear Market Rallies: The Nascent Narcotic

The 2018-2019 bear market rally that we identified during the last week of 2018 via the 2019 Forecast Issue, entitled " 2019: Mayhem, Misallocation and the Mockery of True Price Discovery ," is now on record as one of the most ferocious rallies ever recorded, as short sel...
Streetwise Reports | March 5, 2019 |

Storm Clouds on the Horizon

Sector expert Michael Ballanger discusses macroeconomic factors and his trading decisions. I have had more than a few emails asking me what I think of the current set-up for stocks, bonds, currencies and gold since everything began to re-inflate a few days a...
Streetwise Reports | June 11, 2019 |

The Only 'Bubble' That Counts

Ever since Sept. 19, 2008, when Hammerin' Hank Paulson appeared in front of the U.S. Congress on bended knee and begged those clueless politicians for a bailout—which he did successfully—the spread of moral hazard throughout the world has been a contagion that makes the...
Streetwise Reports | January 21, 2020 |

The Depravity of the False Flag

"Never let a good crisis go to waste." —Sir Winston Churchill My late older brother Donnie was a quasi-anarchist tax collector for the Canadian government who self-educated himself and then morphed from a grumbling, cynical security guard/starving artist to a very succe...
Streetwise Reports | March 24, 2020 |

Valeo Pharma Big Pharma Capabilities Presents Opportunity

Valeo Pharma Inc. is a Canadian specialty pharmaceutical company with big pharma capabilities while retaining small company flexibilities. Valeo is a fast-growing revenue generating company with a strong product portfolio and a robust product pipeline. Valeo Pharma In...
Fredrick William | May 15, 2020 |

Clinical research and tools to address mental health

Our next company is Numinus Wellness Inc. (TSX:NUMI) . Numinus is using the power of psychedelic medicine to make great strides in addressing serious mental health issues. It recently announced its fiscal year 2024 results, which showed strong growth in its busines...
Ryan Dhillon | December 14, 2023 |

3D printing is a manufacturing game-changer

Calling all carnivores: ever thought about getting a meat printer? Of hand-crafting delectable beef steaks at home from plant proteins, that have the same texture, appearance and flavor as real meat, only without the distasteful killing part? 3D-printed steaks and chicken ...
Richard (Rick) Mills | November 15, 2019 |

Will People Accept Rampant Inflation? Hell, No!

The Weekly Missive, which usually arrives over the weekend (sometimes on Friday, sometimes on Sunday) was delayed this weekend for one reason: I had to change it. I started out last week with an idea that was leaning in the direction of full-on capitulation in the sen...
Streetwise Reports | June 24, 2020 |

Buzz on the Bullboards: Hot Sector Favorites

One of the highlights of the Stockhouse Bullboards is that all companies are fair game. In our review of the weekly top 6 most viewed companies by sector, newcomers might expect big household names to dominate the charts. Instead, they find that Stockhouse investors are clued ...
Omri Wallach | September 11, 2019 |

Baudax Shares Rise as FDA Approves NDA for Its Non-Opioid Pain Medication

Shares of Baudax Bio traded more than 20% higher and set a new 52-week high price after reporting that the FDA approved the company's non-opioid ANJESO™ drug for management of moderate to severe pain. Specialty pharmaceutical company Baudax Bio Inc. (BXRX:N...
Streetwise Reports | February 24, 2020 |
1 2 3 4 5 6 7 8 9 10 ...